APP and Alzheimer disease: Amyloid plaques (aggregated amyloid beta-peptides, Aβ) and neurofibrillary tangles (NFTs) are the most common AD molecular hallmarks, but neuroinflammation, oxidative stress, and pre- and post-synaptic alterations, among other disturbed mechanisms, are equally associated risk factors (Tzioras et al., 2023).